Tuberculosis Research Centre
Welcome,         Profile    Billing    Logout  
 15 Trials 
15 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nutman, Thomas B
NCT05706116: Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults

Not yet recruiting
1
18
US
Trichuris trichiura Egg Inoculum
George Washington University, National Institute of Allergy and Infectious Diseases (NIAID)
Whipworm, Trichuriasis, Controlled Human Infection
10/26
04/28
NCT00001230: Host Response to Infection and Treatment in Filarial Diseases

Recruiting
N/A
500
US
Diethylcarbamazine
National Institute of Allergy and Infectious Diseases (NIAID)
Filariasis, Helminthiasis, Parasitic Infection, Mansonelliasis, Onchocerciasis
 
 
NCT00001645: Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

Recruiting
N/A
500
US
National Institute of Allergy and Infectious Diseases (NIAID)
Malaria, Intestinal Worms, GI Protozoa, Echiniococcus, Strongyloides
 
 
NCT04526613: The Influence of Malnutrition, Diabetes Mellitus, and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population

Active, not recruiting
N/A
626
RoW
National Institute of Allergy and Infectious Diseases (NIAID)
Mycobacterium Tuberculosis, LTBI (Latent TB Infection), Malnutrition, Diabetes Mellitus, Helminth Infections
06/25
06/25
COMBINE-TB, NCT04642755: Comorbidities and Coinfections in Latent TB

Recruiting
N/A
300
RoW
Tuberculosis Research Centre, India, National Institutes of Health (NIH)
Latent Tuberculosis, Diabete Mellitus, Malnutrition, Helminth Infection
03/26
03/26
Babu, Subash
COVID-19-TB, NCT04930978: Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis

Recruiting
N/A
250
RoW
Tuberculosis Research Centre, India
COVID-19 Respiratory Infection, Pulmonary Tuberculoses
06/24
06/24
NCT05049187: Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers

Completed
N/A
132
RoW
Tuberculosis Research Centre, India, National Institute of Epidemiology
Covid19
03/23
03/23
MISC-COVID, NCT04844242: MISC COVID-19 Study in Pediatric Population

Recruiting
N/A
180
RoW
Tuberculosis Research Centre, India, National Institutes of Health (NIH)
SARS-CoV2 Infection, Multisystem Inflammatory Syndrome in Children
12/24
12/24
NCT04813328: The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms

Recruiting
N/A
1500
RoW
National Institute of Allergy and Infectious Diseases (NIAID)
COVID-19
04/25
04/25
COMBINE-TB, NCT04642755: Comorbidities and Coinfections in Latent TB

Recruiting
N/A
300
RoW
Tuberculosis Research Centre, India, National Institutes of Health (NIH)
Latent Tuberculosis, Diabete Mellitus, Malnutrition, Helminth Infection
03/26
03/26
Guleria, Randeep
NCT04919239: Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

Active, not recruiting
2
140
RoW
RUTI®, Placebo
Archivel Farma S.L.
Tuberculosis, Pulmonary
03/25
03/25
NCT03869528: 5 Versus 10 Sprays of Lignocaine for Pharyngeal Anaesthesia During Bronchoscopy

Recruiting
N/A
300
RoW
5 sprays of 10% lignocaine, 5 sprays, 10 sprays of 10% lignocaine, 10 sprays
All India Institute of Medical Sciences, New Delhi
Bronchoscopy, Anesthesia, Local
12/21
12/21
Mohan, Anant
NCT04358809: Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill

Recruiting
3
480
RoW
Suspension of heat killed (autoclaved) Mycobacterium w, Placebo
Cadila Pharnmaceuticals, Council of Scientific and Industrial Research, India
COVID-19
02/21
04/21
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Terminated
3
409
Europe, US, RoW
Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo
Dompé Farmaceutici S.p.A
Infectious Pneumonia, Severe COVID-19
09/24
09/24
Chandrasekaran, Padmapriyadarsini
INSHORT, NCT05917340: Intensified Short Course Regimen for TBM in Adults

Not yet recruiting
3
372
RoW
High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg, Isoniazid, Pyrazinamide, Steroid, Rifampicin, HRZE, HRE
Indian Council of Medical Research, All India Institute of Medical Sciences, Jodhpur, Christian Medical College, Vellore, India, Jawaharlal Institute of Postgraduate Medical Education & Research, North Eastern Indira Gandhi Regional Institute of Health ans Medical Sciences, Madras Medical College, Rural Development Trust Hospital
Tuberculous Meningitis
09/27
09/27
R, Tiwari R
No trials found

Download Options